Chase Investment Counsel Corp Abbott Laboratories Transaction History

Chase Investment Counsel Corp

  • $299 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
SELL
$105.79 - $124.53 $2.09 Million - $2.46 Million
-19,755 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$108.84 - $128.23 $1.38 Million - $1.63 Million
12,711 Added 180.45%
19,755 $2.37 Million
Q4 2020

Feb 02, 2021
BUY
$105.0 - $114.42 $739,620 - $805,974
7,044 New
7,044 $771,000

Others Institutions Holding ABT

# of Institutions
3,238
Shares Held
1.31B
Call Options Held
8.71M
Put Options Held
8.03M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $225B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Chase Investment Counsel Corp Portfolio

Follow Chase Investment Counsel Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

News

Stay updated on Chase Investment Counsel Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email